Coordinated post-transcriptional regulation of the chemokine system: Messages from CCL2

Journal of Interferon and Cytokine Research

Volumn 34, Issue 4, 2014, Pages 255-266

  Panganiban, Ronaldo P ^a   Vonakis, Becky M ^b   Ishmael, Faoud T ^a   Stellato, Cristiana ^b,c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE SYSTEM; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RESPONSE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOPATHOGENESIS; MOLECULAR INTERACTION; NONHUMAN; PNEUMONIA; POST TRANSCRIPTIONAL GENE REGULATION; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; IMMUNOLOGY; INFLAMMATION; LUNG DISEASE; METABOLISM; PROTEIN PROCESSING; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INFLAMMATION; LUNG DISEASES; MICRORNAS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR CROSS-TALK; RESPIRATORY MUCOSA; RNA-BINDING PROTEINS; TH1 CELLS; TH2 CELLS; TRANSCRIPTOME;

EID: 84898731026     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0149     Document Type: Review

References (104)

1. Al-Ahmadi W, Al-Ghamdi M, Al-Haj L, Al-Saif M, Khabar KS. 2009. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res 37(11):3612-3624.
2. Anderson P. 2008. Post-transcriptional control of cytokine production. Nat Immunol 9(4):353-359.
3. Anderson P. 2009. Intrinsic mRNA stability helps compose the inflammatory symphony. Nat Immunol 10(3):233-234.
4. Anderson P. 2010. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10(1):24-35.
5. Arner E, Mejhert N, Kulyté A, Balwierz PJ, Pachkov M, Cormont M, Lorente-Cebrián S, Ehrlund A, Laurencikiene J, Hedén P, Dahlman-Wright K, Tanti JF, Hayashizaki Y, Rydén M, Dahlman I, van Nimwegen E, Daub CO, Arner P. 2012. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61(8):1986-1993.
6. Atasoy U, Curry SL, López de Silanes I, Shyu AB, Casolaro V, Gorospe M, Stellato C. 2003. Regulation of eotaxin gene expression by TNF and IL-4 through messenger RNA stabilization: involvement of the RNA-binding protein HuR. J Immunol 171(8):4369-4378.
7. Bakheet T, Williams BR, Khabar KS. 2006. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34(Database issue):D111-D114.
8. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. 2008. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9(8):839-845.
9. Berkman N, John M, Roesems G, Jose P, Barnes P, Chung K. 1995. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol 155(9): 4412-4418.
10. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. 2006. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125(6): 1111-1124.
11. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD. 2000a. Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 28(2):76-83.
12. Blaxall BC, Pellett AC, Wu SC, Pende A, Port JD. 2000b. Purification and characterization of beta-adrenergic receptor mRNA-binding proteins. J Biol Chem 275(6):4290-4297.
13. Brewer BY, Malicka J, Blackshear PJ, Wilson GM. 2004. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of AU-rich mRNA-destabilizing motifs. J Biol Chem 279(27):27870-27877.
14. Carballo E, Lai WS, Blackshear PJ. 2000. Evidence that tristetraprolin is a physiological regulator of granulocytemacrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95(6):1891-1899.
15. Casolaro V, Fang X, Tancowny B, Fan J, Wu F, Srikantan S, Asaki SY, De Fanis U, Huang SK, Gorospe M, Atasoy UX, Stellato C. 2008. Posttranscriptional regulation of IL-13 in T cells: role of the RNA-binding protein HuR. J Allergy Clin Immunol 121(4):853-859 e4.
16. Charo IF, Peters W. 2003. Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization. Microcirculation 10(3-4):259-264.
17. Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610-621.
18. Clark AR. 2007. Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 275(1-2):79-97.
19. Clark AR, Dean JL, Saklatvala J. 2003. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett 546(1):37-44.
20. Clark AR, Lasa M. 2003. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 3(4):404-411.
21. Clark AR, Martins JR, Tchen CR. 2008. Role of dual specificity phosphatases in biological responses to glucocorticoids. J Biol Chem 283(38):25765-25769.
22. Daly C, Rollins BJ. 2003. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10(3-4):247-257.
23. Datta S, Biswas R, Novotny M, Pavicic PG, Jr., Herjan T, Mandal P, Hamilton TA. 2008. Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol 180(4):2545-2552.
24. Datta S, Novotny M, Pavicic PG, Jr., Zhao C, Herjan T, Hartupee J, Hamilton T. 2010. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence. J Immunol 184(3):1484-1491.
25. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. 2001. The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21(3):721-730.
26. Deshmane SL, Kremlev S, Amini S, Sawaya BE. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29(6):313-326.
27. Dhawan L, Liu B, Blaxall BC, Taubman MB. 2007. A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability 10.1074/jbc.M605925200. J Biol Chem 282(14):10146-10152.
28. Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA, Prescott SM. 2001. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108(11):1657-1665.
29. Fan J, Heller NM, Gorospe M, Atasoy U, Stellato C. 2005. The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur Respir J 26(5): 933-947.
30. Fan J, Ishmael FT, Fang X, Myers A, Cheadle C, Huang SK, Atasoy U, Gorospe M, Stellato C. 2011. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol 186(4):2482-2494.
31. Ford LP, Watson J, Keene JD, Wilusz J. 1999. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13(2): 188-201.
32. Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR. 2003. p38 Mitogen-activated protein kinasedependent and-independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 23(2):425-436.
33. Goldberg-Cohen I, Furneauxb H, Levy AP. 2002. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 277(16):13635-13640.
34. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404(6776):407-411.
35. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M, Jr., Jungkamp AC, Munschauer M, Ulrich A, Wardle GS, Dewell S, Zavolan M, Tuschl T. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PARCLIP. Cell 141(1):129-141.
36. Hamilton T, Novotny M, Pavicic PJ, Jr., Herjan T, Hartupee J, Sun D, Zhao C, Datta S. 2010. Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression. Cytokine 52(1-2):116-122.
37. Hinman MN, Lou H. 2008. Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65(20):3168-3181.
38. Houser KR, Johnson DK, Ishmael FT. 2012. Anti-inflammatory effects of methoxyphenolic compounds on human airway cells. J Inflamm (Lond) 9:6.
39. Ishmael FT, Fang X, Galdiero MR, Atasoy U, Rigby WF, Gorospe M, Cheadle C, Stellato C. 2008. Role of the RNAbinding protein tristetraprolin in glucocorticoid-mediated gene regulation. J Immunol 180(12):8342-8353.
40. Ishmael FT, Fang X, Houser KR, Pearce K, Abdelmohsen K, Zhan M, Gorospe M, Stellato C. 2011. The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif. J Immunol 186(2):1189-1198.
41. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162):557-563.
42. Katsanou V, Papadaki O, Milatos S, Blackshear PJ, Anderson P, Kollias G, Kontoyiannis DL. 2005. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 19(6):777-789.
43. Kedersha N, Chen S, Gilks N, Li W, Miller IJ, Stahl J, Anderson P. 2002. Evidence that ternary complex (eIF2-GTPtRNA( i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol Biol Cell 13(1):195-210.
44. Kedersha N, Cho MR, Li W, Yacono PW, Chen S, Gilks N, Golan DE, Anderson P. 2000. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol 151(6):1257-1268.
45. Keene JD. 2001. Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 98(13):7018-7024.
46. Keene JD. 2007. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8(7):533-543.
47. Keene JD, Komisarow JM, Friedersdorf MB. 2006. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc 1(1):302-307.
48. Kim HS, Armstrong D, Hamilton TA, Tebo JM. 1998. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J Leukoc Biol 64(1):33-39.
49. Kishore R, Tebo JM, Kolosov M, Hamilton TA. 1999. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J Immunol 162(5):2457-2461.
50. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10(3):387-398.
51. Kracht M, Saklatvala J. 2002. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20(3):91-106.
52. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. 2006. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTPdeficient fibroblasts. Mol Cell Biol 26(24):9196-9208.
53. Levy NS, Chung S, Furneaux H, Levy AP. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273(11):6417-6423.
54. Liang J, Lei T, Song Y, Yanes N, Qi Y, Fu M. 2009. RNAdestabilizing factor tristetraprolin negatively regulates NFkappaB signaling. J Biol Chem 284(43):29383-29390.
55. Lin FY, Tsai YT, Lee CY, Lin CY, Lin YW, Li CY, Shih CM, Huang CY, Chang NC, Tsai JC, Chen TL, Tsai CS. 2011. TNF-alpha-decreased thrombomodulin expression in monocytes is inhibited by propofol through regulation of tristetraprolin and human antigen R activities. Shock 36(3): 279-288.
56. Lopez de Silanes I, Galban S, Martindale JL, Yang X, Mazan-Mamczarz K, Indig FE, Falco G, Zhan M, Gorospe M. 2005. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol 25(21): 9520-9531.
57. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. 2004. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101(9):2987-2992.
58. Love TM, Moffett HF, Novina CD. 2008. Not miR-ly small RNAs: big potential for microRNAs in therapy. J Allergy Clin Immunol 121(2):309-319.
59. Lu TX, Rothenberg ME. 2013. Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol 132(1):3-13; quiz 14.
60. Luther SA, Cyster JG. 2001. Chemokines as regulators of T cell differentiation. Nat Immunol 2(2):102-107.
61. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271(14):8144-8151.
62. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, Georas SN, Casolaro V, Schleimer RP. 1999. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 163(12):6876-6883.
63. Mattes J, Yang M, Foster PS. 2007. Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? Am J Respir Cell Mol Biol 36(1):8-12.
64. Ming XF, Stoecklin G, Lu M, Looser R, Moroni C. 2001. Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogenactivated protein kinase. Mol Cell Biol 21(17):5778-5789.
65. Murray PJ, Smale ST. 2012. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 13(10):916-924.
66. Nabors LB, Gillespie GY, Harkins L, King PH. 2001. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine-and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61(5):2154-2161.
67. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH. 2003. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res 63(14):4181-4187.
68. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, Kumagai S. 2009. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 60(5):1294-1304.
69. Novotny M, Datta S, Biswas R, Hamilton T. 2005. Functionally independent AU-rich sequence motifs regulate KC (CXCL1) mRNA. J Biol Chem 280(34):30166-30174.
70. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL. 2012. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res 91(7):651-658.
71. Panganiban RP, Pinkerton MH, Maru SY, Jefferson SJ, Roff AN, Ishmael FT. 2012. Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5. Am J Clin Exp Immunol 1(2):154-165.
72. Papadaki O, Milatos S, Grammenoudi S, Mukherjee N, Keene JD, Kontoyiannis DL. 2009. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J Immunol 182(11):6779-6788.
73. Pinkerton M, Chinchilli V, Banta E, Craig T, August A, Bascom R, Cantorna M, Harvill E, Ishmael FT. 2013. Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J Allergy Clin Immunol 132(1):217-219.
74. Poon M, Liu B, Taubman MB. 1999. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol Cell Biol 19(10):6471-6478.
75. Prechtel AT, Chemnitz J, Schirmer S, Ehlers C, Langbein-Detsch I, Stulke J, Dabauvalle M-C, Kehlenbach RH, Hauber J. 2006. Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. J Biol Chem 281(16):10912-10925.
76. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222-225.
77. Rodriguez-Pascual F, Hausding M, Ihrig-Biedert I, Furneaux H, Levy AP, Forstermann U, Kleinert H. 2000. Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem 275(34):26040-26049.
78. Roff AN, Panganiban RP, Bond JS, Ishmael FT. 2013. Posttranscriptional regulation of meprin alpha by the RNAbinding proteins Hu antigen R (HuR) and tristetraprolin (TTP). J Biol Chem 288(7):4733-4743.
79. Rose CE, Jr., Sung SS, Fu SM. 2003. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10(3-4):273-288.
80. Ross J. 1995. mRNA stability in mammalian cells. Microbiol Rev 59(3):423-450.
81. Sakai K, Kitagawa Y, Saiki M, Saiki S, Hirose G. 2003. Binding of the ELAV-like protein in murine autoimmune T-cells to the nonameric AU-rich element in the 3' untranslated region of CD154 mRNA. Mol Immunol 39(14):879-883.
82. Sandler H, Stoecklin G. 2008. Control of mRNA decay by phosphorylation of tristetraprolin. Biochem Soc Trans 36(Pt 3):491-496.
83. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. 2007. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 120(6):1279-1284.
84. Shi L, Godfrey WR, Lin J, Zhao G, Kao PN. 2007. NF90 regulates inducible IL-2 gene expression in T cells. J Exp Med 204(5):971-977.
85. Smoak K, Cidlowski JA. 2006. Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol 26(23):9126-9135.
86. Stefanska J, Pawliczak R. 2008. Apocynin: molecular aptitudes. Mediators Inflamm 2008:106507.
87. Stefanska J, Sarniak A, Wlodarczyk A, Sokolowska M, Pniewska E, Doniec Z, Nowak D, Pawliczak R. 2012. Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics. Exp Lung Res 38(2):90-99.
88. Stellato C. 2004. Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc 1:255-263.
89. Stellato C. 2007. Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets. J Allergy Clin Immunol 120(6):1247-1263; quiz 1264-1265.
90. Stellato C, Beck LA. 2000. Expression of eosinophil-specific chemokines by human epithelial cells. Chem Immunol 76: 156-176.
91. Stellato C, Gubin MM, Magee JD, Fang X, Fan J, Tartar DM, Chen J, Dahm GM, Calaluce R, Mori F, Jackson GA, Casolaro V, Franklin CL, Atasoy U. 2011. Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR. J Immunol 187(1):441-449.
92. Stellato C, Matsukura S, Fal A, White J, Beck LA, Proud D, Schleimer RP. 1999. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 163(10):5624-5632.
93. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283(17):11689-11699.
94. Tauler J, Mulshine JL. 2009. Lung cancer and inflammation: interaction of chemokines and hnRNPs. Curr Opin Pharmacol 9(4):384-388.
95. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4(5):445-454.
96. Tenenbaum SA, Lager PJ, Carson CC, Keene JD. 2002. Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26(2):191-198.
97. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM. 1994. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83(9):2678-2683.
98. Wang W, Fan J, Yang X, Furer-Galban S, Lopez de Silanes I, von Kobbe C, Guo J, Georas SN, Foufelle F, Hardie DG, Carling D, Gorospe M. 2002. AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol 22(10):3425-3436.
99. Wang W, Yang X, Kawai T, Lopez de Silanes I, Mazan-Mamczarz K, Chen P, Chook YM, Quensel C, Kohler M, Gorospe M. 2004. AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1: involvement in the nuclear import of RNA-binding protein HuR. J Biol Chem 279(46):48376-48388.
100. White GE, Iqbal AJ, Greaves DR. 2013. CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges. Pharmacol Rev 65(1): 47-89.
101. Yarovinsky TO, Butler NS, Monick MM, Hunninghake GW. 2006. Early Exposure to IL-4 Stabilizes IL-4 mRNA in CD4 + T Cells via RNA-Binding Protein HuR. J Immunol 177(7):4426-4435.
102. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA. 2009. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136(5):1669-1679.
103. Zhai Y, Zhong Z, Chen CY, Xia Z, Song L, Blackburn MR, Shyu AB. 2008. Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation. Mol Cell Biol 28(24):7414-7426.
104. Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, Li C, Chong M, Ibrahim T, Mercatali L, Amadori D, Lu X, Xie D, Li QJ, Wang XF. 2013. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 15(3):284-294.